Apnimed, Inc. Common Stock (APMD)
Apnimed, Inc. Common Stock (APMD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.
As of Oct 23, 2026: market cap $771M; returns 1 day +2.5%, 1 week +6.9%.
Apnimed, Inc. (APMD) is a late-stage clinical pharmaceutical company primarily focused on the development of oral pharmacological treatments for Obstructive Sleep Apnea (OSA).
Groups APMD belongs to
- Recent IPOs
- Sleep Apnea
- Biotechnology
- Clinical Stage Biotech
- Pharmaceuticals
- Healthcare
- Biopharmaceutical
- Life Sciences
- Clinical Stage
APMD financial model: income statement, cash flow and balance sheet